MARSHALL WACE, LLP - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,615,000
+132.0%
80,116
+153.6%
0.01%
+75.0%
Q4 2020$696,000
-63.3%
31,591
-70.0%
0.00%
-66.7%
Q3 2020$1,896,000
-58.3%
105,409
-57.4%
0.01%
-73.3%
Q1 2020$4,550,000
-78.9%
247,695
-74.7%
0.04%
-69.6%
Q4 2019$21,586,000
+868.4%
979,870
+531.0%
0.15%
+722.2%
Q3 2019$2,229,000
-62.4%
155,287
-61.6%
0.02%
-35.7%
Q1 2019$5,926,000404,4260.03%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$74,954,00012.68%
Aquilo Capital Management, LLC 1,237,379$22,731,0008.86%
EcoR1 Capital, LLC 3,346,301$61,472,0006.42%
RTW INVESTMENTS, LP 6,963,135$127,913,0005.51%
BRIDGER MANAGEMENT, LLC 1,679,344$30,850,0003.57%
Parkman Healthcare Partners LLC 300,805$5,526,0002.56%
ACUTA CAPITAL PARTNERS, LLC 256,500$4,712,0002.28%
Integral Health Asset Management, LLC 185,000$3,398,0001.50%
DAFNA Capital Management LLC 147,714$2,714,0001.13%
EAM Global Investors LLC 88,465$1,625,0000.95%
View complete list of DICERNA PHARMACEUTICALS INC shareholders